HAVN Life Sciences Inc.
-
Head Office:
605 130 Brew St., Port Moody, BC V3H0E3 CAN -
Reporting Since:
2020-09-02
Previous Names:
N/A
Issuer Status:
Cease Traded as of 2023-11-09
Management Cease Traded as of 2023-08-29
In Default as of 2023-08-29
Year End:
April 30Principal Regulator:
British ColumbiaDefault History
| Period of Default | Default Code | Default From | Default To |
|---|---|---|---|
|
Q1 2023-07-31
|
1b.,1c.,1e.,3
|
2023-10-03
|
|
|
A 2023-04-30
|
1a.,1c.,1e.,3
|
2023-08-29
|
|
|
Q3 2023-01-31
|
1b.,1c.,1e.,3
|
2023-04-04
|
2023-04-05
|
|
Q2 2022-10-31
|
1b.,1c.,1e.,3
|
2023-01-03
|
2023-01-26
|
Historical Exempt Distributions
Exempt Distribution filings made after 25-July-2023 can be viewed in SEDAR+
| Exemption | Document Type | Distribution From | Distribution To | $ Amount Raised | Filing Date |
|---|---|---|---|---|---|
|
NI 45-106 2.14
|
2022-01-13
|
2022-01-13
|
30000.0000
|
2022-01-20
|
|
|
NI 45-106 2.14
|
2020-09-14
|
2020-09-14
|
97600.0000
|
2020-09-21
|
|
|
NI 45-106 2.3, NI 45-106 2.5
|
2020-06-01
|
2020-06-05
|
1577400.0000
|
2020-06-10
|
Exemption Orders
Nothing on File